Health
The Lundquist Institute out-licenses development of a synthetic lung surfactant formulation – EurekAlert
TLI-Gates MRI agreement advances evolution of synthetic lung surfactants to treat respiratory distress syndrome in premature infants in low- and middle-income countries….
-AGREEMENT ADVANCES EVOLUTION OF SYNTHETIC LUNG SURFACTANTS TO TREAT RESPIRATORY DISTRESS SYNDROME IN PREMATURE INFANTS IN LOW- AND MIDDLE-INCOME COUNTRIES-
LOS ANGELES (March 8, 2021) — The Lundquist Institute (TLI) and The Bill & Melinda Gates Medical Research Institute (Gates MRI) executed a license agreement for TLI intellectual property covering a synthetic lung surfactant formulation to be developed for respiratory distress syndrome (RDS) for premature infants in Low- and Middle-Income countries…
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News23 hours agoRainbow Beach surfer’s untold 7/7 story
-
Noosa News13 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Business20 hours agoInvested $10,000 in Westpac shares 2 years ago? Guess how much you’ve already banked!